3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Motor Activity
1
Lymphoma
1
Leukemia
1
Interventions
Cyclophosphamide
73
Rituximab
59
Specimen Handling
49
Biopsy
42
Doxorubicin
41
Vincristine
40
Magnetic Resonance Spectroscopy
39
Prednisone
36
venetoclax
28
obinutuzumab
27
fludarabine
26
ibrutinib
22
Methotrexate
22
Dexamethasone
21
Cytarabine
21
Lenalidomide
20
blinatumomab
19
Etoposide
19
merphos
17
zanubrutinib
16
acalabrutinib
16
prednylidene
15
fludarabine phosphate
15
deltacortene
15
X-Rays
14
Mercaptopurine
14
Bendamustine Hydrochloride
14
pegaspargase
13
Calcium Dobesilate
13
CT-P10
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Roflumilast
×
Lymphoid
×
30 days
×
Clear all
NCT06643221
2026-06-05
Allo-X
University of Arizona
Phase EARLY_PHASE1
Recruiting
200 enrolled